14-day Premium Trial Subscription Try For FreeTry Free
$4.41
+0.0100 (+0.227%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 EGRX stock ended at $4.41. This is 0.227% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 8.54% from a day low at $4.24 to a day high of $4.60.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Eagle Pharmaceuticals prices

Date Open High Low Close Volume
Dec 13, 2021 $46.33 $48.45 $45.31 $47.17 111 372
Dec 10, 2021 $46.54 $47.05 $45.04 $45.82 113 390
Dec 09, 2021 $46.79 $46.79 $45.10 $45.94 110 001
Dec 08, 2021 $49.59 $49.59 $46.36 $46.67 93 116
Dec 07, 2021 $47.05 $48.07 $46.37 $47.62 82 679
Dec 06, 2021 $47.59 $47.76 $45.36 $46.63 107 880
Dec 03, 2021 $48.28 $48.50 $47.18 $47.42 80 936
Dec 02, 2021 $47.72 $49.02 $47.72 $48.60 68 211
Dec 01, 2021 $48.10 $49.00 $47.62 $47.86 86 242
Nov 30, 2021 $47.24 $47.99 $46.41 $47.68 94 800
Nov 29, 2021 $48.75 $49.13 $47.48 $47.76 59 062
Nov 26, 2021 $49.53 $49.91 $47.77 $48.10 62 521
Nov 24, 2021 $51.13 $51.61 $50.13 $50.22 52 598
Nov 23, 2021 $50.18 $51.45 $49.51 $50.82 109 060
Nov 22, 2021 $49.50 $50.91 $49.14 $50.19 91 935
Nov 19, 2021 $50.49 $50.49 $49.12 $49.47 63 591
Nov 18, 2021 $51.44 $51.84 $49.95 $49.96 74 609
Nov 17, 2021 $51.22 $52.12 $51.22 $51.36 94 777
Nov 16, 2021 $50.75 $51.64 $49.80 $51.52 91 279
Nov 15, 2021 $52.04 $52.04 $50.64 $50.98 74 049
Nov 12, 2021 $52.18 $52.20 $50.79 $51.50 38 449
Nov 11, 2021 $51.64 $52.45 $51.55 $52.18 33 729
Nov 10, 2021 $51.10 $52.10 $50.86 $51.71 58 288
Nov 09, 2021 $49.22 $52.26 $49.22 $51.40 73 138
Nov 08, 2021 $52.23 $52.30 $50.95 $51.09 74 522
Click to get the best stock tips daily for free!

About Eagle Pharmaceuticals

Eagle Pharmaceuticals Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium ... EGRX Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT